Psilocybin, the active compound found in magic mushrooms, is gaining attention for its potential therapeutic benefits and its evolving legal status across the U.S. In Vermont, interest in psilocybin is growing as more research highlights its promise in treating mental health conditions. While psilocybin remains illegal in Vermont, many are advocating for its decriminalization or medical use. This article covers everything you need to know about psilocybin in Vermont, including current laws, potential health benefits, ongoing research, and what the future might hold for psilocybin in the Green Mountain State.
What is Psilocybin?
Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms, commonly referred to as “magic mushrooms.” Chemically, psilocybin is a prodrug, meaning it is converted into its active form, psilocin, after ingestion. Psilocin interacts with serotonin receptors in the brain, particularly the 5-HT2A receptor, leading to altered sensory perceptions, mood changes, and profound shifts in consciousness.
Scientific studies have shown that psilocybin has significant potential therapeutic applications, particularly in treating conditions such as depression, anxiety, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and substance use disorders, among others. However, psilocybin remains classified as a Schedule I substance under federal law, indicating a high potential for abuse and no recognized medical use, despite ongoing clinical research that challenges this classification.
 into law that established the Psychedelic Therapy Advisory Working Group. This committee has been tasked with examining the use of psychedelics in improving physical and mental health and making recommendations regarding the establishment of a state program similar to those in Colorado or Oregon. In other words, the core purpose of the group is to determine whether magic mushrooms should be made legal for individual consumption. The group includes representatives from various organizations, including the Department of Mental Health, the Vermont Psychological Association, and other community partners.
After November 15, 2024, The Vermont Psychedelic Therapy Advisory Working Group has concluded that the state requires additional research infrastructure before implementing psychedelic-assisted therapy programs. Their evaluation emphasizes the need for expanded clinical studies, particularly focused on psilocybin’s potential role in end-of-life care for patients experiencing depression and anxiety. The working group has requested legislative support to broaden their research scope and increase participant numbers in Vermont-based studies. Notably, several members maintain that FDA approval should precede any state-level implementation of these therapies.
Personal Use and Possession Limits
Currently, psilocybin is classified as a hallucinogenic drug under Vermont law and possession is illegal. The penalties for possession vary based on the amount:
- <10 doses: Up to one year in prison or a fine of up to $2,000, or both
- 10 to 99 doses: Up to five years in prison or a fine of up to $25,000, or both
- 100 to 999 doses: Up to 10 years in prison or a fine of up to $100,000, or both
- >1,000: Up to 15 years in prison or a fine of up to $500,000, or both
Note that there are additional penalties for the sale or dispensing of psilocybin and other psychedelic drugs.
Accessing Psilocybin Legally in Vermont
Under Vermont’s drug laws in 2024, it is not possible to access psilocybin legally in the state. The possession of magic mushrooms or any psychedelic mushrooms is considered a felony offense. If you’re caught with these types of mushrooms, you could face serious legal consequences.
Vermont is taking a cautious approach to the legalization of psychedelic therapies, focusing on further research and monitoring the developments in other states like Colorado and Oregon where psilocybin treatments are available.
Odyssey offers both psilocybin group retreats and private experiences that are fully legal, scientifically backed, and professionally guided – get matched to the right experience for you.
Medical & Therapeutic Applications of Psilocybin
Mental Health Treatment
Psilocybin, the active compound in “magic mushrooms,” has shown promising results in treating various mental health conditions. The latest research suggests that psilocybin-assisted therapy (P-AT) may have significant benefits for individuals suffering from obsessive-compulsive disorder (OCD), and anxiety, as well as eating and addiction disorders. Studies have also demonstrated that psilocybin may be able to facilitate fear extinction and neurogenesis, potentially counteracting the impaired processes associated with post-traumatic stress disorder (PTSD).
In clinical trials, psilocybin has also shown promising early results in treating depression. A study by Johns Hopkins Medicine found that two doses of psilocybin, combined with supportive psychotherapy, produced rapid and substantial reductions in depressive symptoms. Half of the study participants achieved remission through the four-week follow-up. Furthermore, the antidepressant effects of psilocybin-assisted therapy may last at least a year for some patients.
Explore more: Psilocybin Therapy for Depression and Psilocybin Therapy for Obsessive Compulsive Disorder (OCD)
